News

VIDEO: Longer period of postpartum thromboembolic risk raises therapeutic questions


 

Findings from a large study of women following their first pregnancy extend the postpartum period of heightened risk for thromboembolic events from the previously known 6 weeks to 12 weeks, leaving physicians with new questions that need to be answered in further studies about the need for longer periods of anticoagulation therapy in some women. In a video interview, Dr. Bruce Ovbiagele of the Medical University of South Carolina, Charleston, comments on the findings at the International Stroke Conference. The study also was published Feb. 13 in the New England Journal of Medicine in conjunction with the report at the conference (2014 Feb. 13 [doi:10.1056/NEJMoa1311485).

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

Former JNC 8 hypertension panel issues minority report
MDedge Cardiology
New stroke guidelines focus on women’s risks
MDedge Cardiology
New tools for stroke prediction in atrial fibrillation
MDedge Cardiology
NSAID makers argue against new warnings on CV risks
MDedge Cardiology
No new cardiovascular warnings needed for NSAIDs say FDA advisers
MDedge Cardiology
Video: Positive trends for outcomes in uric acid stroke trial gives optimism
MDedge Cardiology
Video: Study hints uric acid reduces acute stroke symptoms
MDedge Cardiology
Uric acid for stroke trials to continue
MDedge Cardiology
VIDEO: Postpartum elevated thrombosis risk lasts 12 weeks
MDedge Cardiology
Postpartum thrombosis risk high for 12 weeks
MDedge Cardiology

Related Articles